Results 171 to 180 of about 10,900 (261)

Nirsevimab in High-Risk Infants in a Respiratory Syncytial Virus Prevention Strategy.

open access: yesJAMA Netw Open
Sauré D   +10 more
europepmc   +1 more source

Genomic Surveillance and Antigenic Characterization of Respiratory Syncytial Virus (RSV) in Spain During the 2023-2024 Season of Nirsevimab Administration. [PDF]

open access: yesJ Infect Dis
Iglesias-Caballero M   +22 more
europepmc   +1 more source

Palivizumab.

open access: yesIndian pediatrics, 2002
D, Gupta, P, Gupta
openaire   +1 more source

iBody-mediated tuning of synthetic cytokine receptor activation via rational nanobody interface engineering. [PDF]

open access: yesMAbs
Kunze R   +7 more
europepmc   +1 more source

RSV Prevention in Infants and Young Children. [PDF]

open access: yesAm J Respir Crit Care Med
Cacho F, Sockrider M.
europepmc   +1 more source

Respiratory syncytial virus immunization in children: The old, the new and what's just around the corner. [PDF]

open access: yesHum Vaccin Immunother
Paes BA   +4 more
europepmc   +1 more source

Modeling the greenhouse gas emissions of an immunization program against respiratory syncytial virus in infants in the United Kingdom. [PDF]

open access: yesInt J Technol Assess Health Care
Hudson RDA   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy